What is Adial Pharmaceuticals, Inc's Market Cap?

Adial Pharmaceuticals, Inc's Market Cap is $18.0M, based on as-reported figures from SEC (XBRL) filings.

What is Adial Pharmaceuticals, Inc's Net Income (TTM)?

Adial Pharmaceuticals, Inc's Net Income (TTM) is -$8.1M, based on as-reported figures from SEC (XBRL) filings.

What is Adial Pharmaceuticals, Inc's EBITDA?

Adial Pharmaceuticals, Inc's EBITDA is -$7.9M, based on as-reported figures from SEC (XBRL) filings.

What is Adial Pharmaceuticals, Inc's Diluted EPS (TTM)?

Adial Pharmaceuticals, Inc's Diluted EPS (TTM) is -3.07, based on as-reported figures from SEC (XBRL) filings.

Adial Pharmaceuticals, Inc (ADIL) Financial Statements

Adial Pharmaceuticals, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00HNGDTS3

XNAS · usd

6.85▲ 0.20 (3.01%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close6.65

Day's Range6.33 – 7.20

52-Week Range0.13 – 7.20

Volume67.6K

Avg Volume77.0K

Share Statistics

Shares Outstanding

Employees6

ExchangeXNAS

Listed2018-07-27

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Adial Pharmaceuticals, Inc (ADIL)

What is Adial Pharmaceuticals, Inc's Market Cap?: Adial Pharmaceuticals, Inc's Market Cap is $18.0M, based on as-reported figures from SEC (XBRL) filings.
What is Adial Pharmaceuticals, Inc's Net Income (TTM)?: Adial Pharmaceuticals, Inc's Net Income (TTM) is -$8.1M, based on as-reported figures from SEC (XBRL) filings.
What is Adial Pharmaceuticals, Inc's EBITDA?: Adial Pharmaceuticals, Inc's EBITDA is -$7.9M, based on as-reported figures from SEC (XBRL) filings.
What is Adial Pharmaceuticals, Inc's Diluted EPS (TTM)?: Adial Pharmaceuticals, Inc's Diluted EPS (TTM) is -3.07, based on as-reported figures from SEC (XBRL) filings.